OTHER
us guided Transversalis fascia plane block
addition of calcitonin to pubivacaine
Status
Recruiting
Phase
Not applicable
Enrollment
70
Locations
1
Results
Not posted
Publications
0
Study summary
Evaluate calcitonin as an adjuvant to bupivacaine in ultrasound guided tansversalis fascia plane block
Interventions
OTHER
addition of calcitonin to pubivacaine
Timeline
First posted
Jun 24, 2025
Study start
Apr 1, 2025
Primary completion
Aug 1, 2025
Study completion
Sep 1, 2025
Results posted
Not reported
Registry updated
Jun 24, 2025
Outcomes
time to first rescue analgesia
Time frame · 24 hours
Not reported in the indexed record.
Eligibility
Inclusion Criteria: * female pt ASA2 scheduled for cs under spinal anesthesia Exclusion Criteria: * patient refusal ASAmore than 3 patients with pregnancy related disease emergency cs history of coagulopathy
Study locations
Egypt. Showing up to 24 locations stored in the fast local snapshot.
tanta University hospital
Tanta, Gharbia Governorate, Egypt
Publications
No PMID-linked publications were present in this registry snapshot.
Related trials
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa · Migraine · Headache
Not applicable
Completed
513
2026-07
Jordan University of Science and Technology · Root Canal Treatment · Postoperative Pain
Not applicable
Active, not recruiting
75
2026-07
Tanta University · Calcitonin · Subcutaneous
Phase 3
Recruiting
168
2026-07
Insel Gruppe AG, University Hospital Bern · Acute Mountain Sickness
Phase 4
Not yet recruiting
30
2026-07
Institut Claudius Regaud · Medullary Thyroid Cancer
Not applicable
Completed
24
2026-06
Rigmor Højland Jensen · Idiopathic Intracranial Hypertension (IIH)
Phase 3
Not yet recruiting
96
2026-06
IRCCS San Raffaele Roma · Episodic Migraine · Chronic Migraine
Not applicable
Recruiting
2,641
2026-06
Pamukkale University · Neck Pain · Text Neck Syndrome
Not applicable
Completed
38
2026-05
Related PeptideStat pages
Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.